UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development

Journal of Cancer, 2017-01, Vol.8 (7), p.1255-1262

2017

Volltextzugriff (PDF)

Guidelines for the management of postoperative soiling in children with Hirschsprung disease

Pediatric surgery international, 2019-08, Vol.35 (8), p.829-834

2019

Volltextzugriff (PDF)

Characterization of Juice Extraction Methods Utilizing Fresh Mayhaw (Crataegus opaca Hook.) Fruit

International journal of fruit science, 2008-12, Vol.8 (4), p.318-331

2008

Volltextzugriff (PDF)

Interim safety analysis of a phase II trial combining trastuzumab and NeuVax, a HER2-targeted peptide vaccine, to prevent breast cancer recurrence in HER2 low expression

Annals of oncology, 2016-10, Vol.27, p.vi366-vi366

2016

Volltextzugriff (PDF)

Abstract P6-10-04: Determining the optimal vaccination strategy using a combination of the folate binding protein (FBP) peptide vaccine (E39+GM-CSF) and an attenuated version (E39') to maximize the immunologic response in breast cancer patients

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-10-04

2017

Volltextzugriff (PDF)

Abstract P2-11-01: Final pre-specified analysis of the phase II trial of the GP2+GM-CSF peptide vaccine in high risk breast cancer patients to prevent recurrence

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-11-01

2016

Volltextzugriff (PDF)

Abstract P4-13-02: Preliminary results for the phase 1 trial of a dual HER2 peptide cancer vaccine in breast and ovarian cancer patients

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-13-02

2013

Volltextzugriff (PDF)

Abstract P2-14-01: Breast cancer patients with HER2 low-expression: An under-recognized group at significant risk for recurrence

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-14-01

2013

Volltextzugriff (PDF)

Abstract P4-13-05: HLA-A2 is not a prognostic indicator in breast cancer: Implications for cancer vaccine trials

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-13-05

2013

Volltextzugriff (PDF)

Abstract P5-16-05: The combination of trastuzumab and HER2-directed peptide vaccines is safe in HER2-expressing breast cancer patients

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-16-05

2012

Volltextzugriff (PDF)

Comparison of Juice Extraction Methods from Fresh and Frozen Mayhaw (Crataegus opacaHook.) Fruit

International journal of fruit science, 2008-02, Vol.7 (3), p.41-64

2008

Volltextzugriff (PDF)

Consumer Acceptance of Mayhaw (Crataegus opaca Hook, and Arn.) Juice Blended with Muscadine Grape (Vitis rotundifolia Michx.) Juice

International journal of fruit science, 2007-06, Vol.6 (3), p.53-65

2007

Volltextzugriff (PDF)

Use of a Commercial Pectolytic Enzyme to Extract Juice from Frozen Mayhaw (Crataegus opaca Hook.) Fruit

International journal of fruit science, 2007-12, Vol.7 (1), p.77-86

2007

Volltextzugriff (PDF)

Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial

Trials, 2018-10, Vol.19 (1), p.593-593, Article 593

2018

Volltextzugriff (PDF)

The impact of margins and re‐resection in pediatric synovial sarcoma

Cancer medicine (Malden, MA), 2024-09, Vol.13 (17), p.e70207-n/a

2024

Volltextzugriff (PDF)

Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence – Implications for vaccine trial design

Clinical immunology (Orlando, Fla.), 2018-10, Vol.195, p.28-35

2018

Volltextzugriff (PDF)

Technology and knowledge document cluster analysis for enterprise R&D strategic planning

International journal of technology management, 2006-01, Vol.36 (4), p.336

2006

Volltextzugriff (PDF)

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

Oncotarget, 2017-02, Vol.8 (9), p.15912-15923

2017

Volltextzugriff (PDF)

Phase Ib Trial Comparing Different Doses and Schedules of a Folate-Binding Protein-Derived Peptide Vaccine, E39, and its Attenuated Version, E39', to Induce Long-Term Folate-Binding Protein-Specific Immunity in Disease-Free Cancer Patients

Journal of the American College of Surgeons, 2016-10, Vol.223 (4), p.S20-S21

2016

Volltextzugriff (PDF)

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation

Journal of Cancer, 2016, Vol.7 (1), p.1-6

2016

Volltextzugriff (PDF)

Correlation between Robust Local Reactions Prompting GM-CSF Dose Reduction to Clinical Response in a Phase II Trial of the GP2+GM-CSF HER2 Peptide Vaccine to Prevent Breast Cancer Recurrence

Journal of the American College of Surgeons, 2015-10, Vol.221 (4), p.S18-S19

2015

Volltextzugriff (PDF)

Abstract CT036: Early trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in ovarian cancer patients

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT036-CT036

2017

Volltextzugriff (PDF)

Abstract CT162: Pre-specified interim analysis in a prospective, randomized phase II trial of trastuzumab vs trastuzumab + NeuVax to prevent breast cancer recurrence in HER2+ breast cancer patients

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT162-CT162

2017

Volltextzugriff (PDF)

A novel cancer vaccine platform utilizing autologous tumor lysate loaded into capped yeast cell wall particles

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.169-169

2017

Volltextzugriff (PDF)

Developing silicon intellectual property E-trade mechanisms for system on chip design and integration

International journal of computer integrated manufacturing, 2007-07, Vol.20 (5), p.423-435

2007

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(55)
Tagungsberichte
(4)

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(10)
Technology
(6)
Humans
(5)
Surgery
(5)
Computer Science
(4)
Engineering
(4)
Immunotherapy
(4)
Juice Extraction
(4)
Mayhaw
(4)
Oncology
(4)
Agriculture
(3)
Child
(3)
Computer Science, Interdisciplinary Applications
(3)
Horticulture
(3)
Operations Research & Management Science
(3)
Pediatrics
(3)
Adolescent
(2)
Breast Cancer
(2)
Child, Preschool
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development

Guidelines for the management of postoperative soiling in children with Hirschsprung disease

Characterization of Juice Extraction Methods Utilizing Fresh Mayhaw (Crataegus opaca Hook.) Fruit

Interim safety analysis of a phase II trial combining trastuzumab and NeuVax, a HER2-targeted peptide vaccine, to prevent breast cancer recurrence in HER2 low expression

Abstract P6-10-04: Determining the optimal vaccination strategy using a combination of the folate binding protein (FBP) peptide vaccine (E39+GM-CSF) and an attenuated version (E39') to maximize the immunologic response in breast cancer patients

Abstract P2-11-01: Final pre-specified analysis of the phase II trial of the GP2+GM-CSF peptide vaccine in high risk breast cancer patients to prevent recurrence

Abstract P4-13-02: Preliminary results for the phase 1 trial of a dual HER2 peptide cancer vaccine in breast and ovarian cancer patients

Abstract P2-14-01: Breast cancer patients with HER2 low-expression: An under-recognized group at significant risk for recurrence

Abstract P4-13-05: HLA-A2 is not a prognostic indicator in breast cancer: Implications for cancer vaccine trials

Abstract P5-16-05: The combination of trastuzumab and HER2-directed peptide vaccines is safe in HER2-expressing breast cancer patients

Comparison of Juice Extraction Methods from Fresh and Frozen Mayhaw (Crataegus opacaHook.) Fruit

Consumer Acceptance of Mayhaw (Crataegus opaca Hook, and Arn.) Juice Blended with Muscadine Grape (Vitis rotundifolia Michx.) Juice

Use of a Commercial Pectolytic Enzyme to Extract Juice from Frozen Mayhaw (Crataegus opaca Hook.) Fruit

Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial

The impact of margins and re‐resection in pediatric synovial sarcoma

Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence – Implications for vaccine trial design

Technology and knowledge document cluster analysis for enterprise R&D strategic planning

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

Phase Ib Trial Comparing Different Doses and Schedules of a Folate-Binding Protein-Derived Peptide Vaccine, E39, and its Attenuated Version, E39', to Induce Long-Term Folate-Binding Protein-Specific Immunity in Disease-Free Cancer Patients

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation

Correlation between Robust Local Reactions Prompting GM-CSF Dose Reduction to Clinical Response in a Phase II Trial of the GP2+GM-CSF HER2 Peptide Vaccine to Prevent Breast Cancer Recurrence

Abstract CT036: Early trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in ovarian cancer patients

Abstract CT162: Pre-specified interim analysis in a prospective, randomized phase II trial of trastuzumab vs trastuzumab + NeuVax to prevent breast cancer recurrence in HER2+ breast cancer patients

A novel cancer vaccine platform utilizing autologous tumor lysate loaded into capped yeast cell wall particles

Developing silicon intellectual property E-trade mechanisms for system on chip design and integration

Suchergebnisse filtern